+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Non-Invasive Liquid Biopsy Market by Technology (Digital PCR, Next Generation Sequencing, Quantitative PCR), Application (Cancer Screening, Infectious Disease Diagnostics, Prenatal Testing), Biomarker, End User - Global Forecast 2025-2030- Product Image
Non-Invasive Liquid Biopsy Market by Technology (Digital PCR, Next Generation Sequencing, Quantitative PCR), Application (Cancer Screening, Infectious Disease Diagnostics, Prenatal Testing), Biomarker, End User - Global Forecast 2025-2030- Product Image
Sale

Non-Invasive Liquid Biopsy Market by Technology (Digital PCR, Next Generation Sequencing, Quantitative PCR), Application (Cancer Screening, Infectious Disease Diagnostics, Prenatal Testing), Biomarker, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 188 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5925108
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The non-invasive liquid biopsy market is rapidly redefining diagnostics and patient monitoring by introducing less intrusive, more adaptive testing methods for healthcare providers worldwide. As new technologies and sector partnerships fuel transformation, senior leaders are exploring its impact on clinical workflows, investment priorities, and supply chain strategies.

Market Snapshot: Non-Invasive Liquid Biopsy Market Overview

The non-invasive liquid biopsy market grew from USD 1.19 billion in 2024 to USD 1.41 billion in 2025, supported by a strong CAGR of 18.18%. The global market is projected to reach USD 3.25 billion by 2030, reflecting accelerating adoption across multiple regions and clinical applications. Growth is driven by widespread demand for earlier disease detection, reduced procedural risk, and robust clinical data supporting integration into oncology, prenatal, and Infectious disease diagnostics.

Scope & Segmentation

This report analyzes the comprehensive landscape of non-invasive liquid biopsy technologies, market segments, and key regions. It provides a detailed assessment of core technological advancements and partnership models shaping industry direction.

  • Technology: Digital PCR, BEAMing, Droplet Digital PCR, Next Generation Sequencing, Targeted Sequencing, Whole Exome Sequencing, Whole Genome Sequencing, Quantitative PCR
  • Application: Cancer Screening, Early Detection, Minimal Residual Disease Monitoring, Infectious Disease Diagnostics, Prenatal Testing, Chromosomal Abnormality Screening, Single Gene Disorder Screening
  • Biomarker: Cell Free DNA, Circulating Tumor DNA, Exosomes
  • End User: Commercial Laboratories, Hospital Laboratories, Research Institutes
  • Region: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, and additional countries), Asia-Pacific (China, India, Japan, Australia, and others)
  • Leading Companies: Roche Diagnostics International AG, Illumina, Inc., Thermo Fisher Scientific, Inc., QIAGEN N.V., Guardant Health, Inc., Natera, Inc., Foundation Medicine, Inc., Grail, Inc., Bio-Rad Laboratories, Inc., Exact Sciences Corporation

Key Takeaways for Senior Decision-Makers

  • Widespread integration of liquid biopsy supports the clinical shift toward earlier detection, reducing the need for invasive tissue sampling and aiding disease surveillance at multiple stages.
  • Adoption accelerates as technologies such as digital PCR and next generation sequencing offer expanded sensitivity, enabling the analysis of rare genetic variants and more complex biomarkers through simple blood draws.
  • Emergence of machine learning and advanced bioinformatics is increasing analytic accuracy, supporting providers in interpreting large volumes of genomic and molecular data more rapidly and precisely.
  • Strategic industry collaborations—including diagnostic companies, academic centers, and laboratory networks—are strengthening data validity and driving co-development of assays tailored to disease-specific and regional needs.
  • The market’s evolution is shaped by the distinct regulatory and reimbursement realities of leading geographies, necessitating tailored growth and commercialization strategies for each market cluster.

Tariff Impact on Liquid Biopsy Supply Chains

Recent United States tariff policies have increased costs for imported liquid biopsy reagents and equipment, impacting procurement strategies. Companies are mitigating risks by diversifying supplier partnerships, regionalizing production, and streamlining workflows to limit cost exposure. These adaptive responses ensure consistent delivery while supporting competitive pricing in shifting regulatory environments.

Methodology & Data Sources

The analysis is built on a combination of primary interviews with clinical leaders, laboratory managers, and regulatory experts, alongside robust secondary research from peer-reviewed publications and market data. Structured triangulation, cross-functional panel validation, and quality assurance protocols underpin all findings and recommendations.

Why This Report Matters

  • Enables executives to understand emerging technology trends and their direct impact on core business models, commercialization, and clinical adoption.
  • Supports informed investment and partnership decisions with detailed coverage of regulatory frameworks, supply chain resilience, and segment-specific shifts.
  • Provides actionable intelligence to align R&D, go-to-market, and regional expansion strategies with the evolving needs of payers, providers, and patients.

Conclusion

The non-invasive liquid biopsy market continues to reshape diagnostic strategies by linking technological innovation with clinical utility. For industry leaders, success relies on adopting resilient supply models and staying ahead of regional regulatory changes while prioritizing patient-centered solutions.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advancements in high-sensitivity ctDNA assays enable earlier cancer detection and monitoring
5.2. Integration of multiomics biomarkers with liquid biopsy for comprehensive disease profiling
5.3. Development of AI-driven algorithms for improved interpretation of circulating tumor DNA signals
5.4. Emergence of standardized preanalytical protocols to reduce variability in sample processing
5.5. Expansion of liquid biopsy applications into prenatal genetic screening and transplant rejection monitoring
5.6. Partnerships between diagnostics firms and pharmaceutical companies to accelerate personalized therapy development
5.7. Regulatory approvals driving adoption of liquid biopsy assays in routine clinical oncology workflows
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Non-Invasive Liquid Biopsy Market, by Technology
8.1. Introduction
8.2. Digital PCR
8.2.1. BEAMing
8.2.2. Droplet Digital PCR
8.3. Next Generation Sequencing
8.3.1. Targeted Sequencing
8.3.2. Whole Exome Sequencing
8.3.3. Whole Genome Sequencing
8.4. Quantitative PCR
9. Non-Invasive Liquid Biopsy Market, by Application
9.1. Introduction
9.2. Cancer Screening
9.2.1. Early Detection
9.2.2. Minimal Residual Disease Monitoring
9.3. Infectious Disease Diagnostics
9.4. Prenatal Testing
9.4.1. Chromosomal Abnormality Screening
9.4.2. Single Gene Disorder Screening
10. Non-Invasive Liquid Biopsy Market, by Biomarker
10.1. Introduction
10.2. Cell Free DNA
10.3. Circulating Tumor DNA
10.4. Exosomes
11. Non-Invasive Liquid Biopsy Market, by End User
11.1. Introduction
11.2. Commercial Laboratories
11.3. Hospital Laboratories
11.4. Research Institutes
12. Americas Non-Invasive Liquid Biopsy Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Non-Invasive Liquid Biopsy Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Non-Invasive Liquid Biopsy Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Roche Diagnostics International AG
15.3.2. Illumina, Inc.
15.3.3. Thermo Fisher Scientific, Inc.
15.3.4. QIAGEN N.V.
15.3.5. Guardant Health, Inc.
15.3.6. Natera, Inc.
15.3.7. Foundation Medicine, Inc.
15.3.8. Grail, Inc.
15.3.9. Bio-Rad Laboratories, Inc.
15.3.10. Exact Sciences Corporation
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. NON-INVASIVE LIQUID BIOPSY MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY BIOMARKER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY BIOMARKER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. NON-INVASIVE LIQUID BIOPSY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. NON-INVASIVE LIQUID BIOPSY MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. NON-INVASIVE LIQUID BIOPSY MARKET: RESEARCHAI
FIGURE 24. NON-INVASIVE LIQUID BIOPSY MARKET: RESEARCHSTATISTICS
FIGURE 25. NON-INVASIVE LIQUID BIOPSY MARKET: RESEARCHCONTACTS
FIGURE 26. NON-INVASIVE LIQUID BIOPSY MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. NON-INVASIVE LIQUID BIOPSY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY DIGITAL PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY BEAMING, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY BEAMING, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY DROPLET DIGITAL PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY DROPLET DIGITAL PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY DIGITAL PCR, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY DIGITAL PCR, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY QUANTITATIVE PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY QUANTITATIVE PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY CANCER SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY CANCER SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY EARLY DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY EARLY DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY MINIMAL RESIDUAL DISEASE MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY MINIMAL RESIDUAL DISEASE MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY CANCER SCREENING, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY CANCER SCREENING, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY PRENATAL TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY PRENATAL TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY CHROMOSOMAL ABNORMALITY SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY CHROMOSOMAL ABNORMALITY SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY SINGLE GENE DISORDER SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY SINGLE GENE DISORDER SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY PRENATAL TESTING, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY PRENATAL TESTING, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY CELL FREE DNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY CELL FREE DNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY CIRCULATING TUMOR DNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY CIRCULATING TUMOR DNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY EXOSOMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY EXOSOMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY COMMERCIAL LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY COMMERCIAL LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY DIGITAL PCR, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY DIGITAL PCR, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY CANCER SCREENING, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY CANCER SCREENING, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY PRENATAL TESTING, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY PRENATAL TESTING, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY DIGITAL PCR, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY DIGITAL PCR, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY CANCER SCREENING, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY CANCER SCREENING, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY PRENATAL TESTING, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY PRENATAL TESTING, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 103. CANADA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 104. CANADA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 105. CANADA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY DIGITAL PCR, 2018-2024 (USD MILLION)
TABLE 106. CANADA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY DIGITAL PCR, 2025-2030 (USD MILLION)
TABLE 107. CANADA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 108. CANADA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 109. CANADA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 110. CANADA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 111. CANADA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY CANCER SCREENING, 2018-2024 (USD MILLION)
TABLE 112. CANADA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY CANCER SCREENING, 2025-2030 (USD MILLION)
TABLE 113. CANADA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY PRENATAL TESTING, 2018-2024 (USD MILLION)
TABLE 114. CANADA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY PRENATAL TESTING, 2025-2030 (USD MILLION)
TABLE 115. CANADA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 116. CANADA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 117. CANADA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. CANADA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. MEXICO NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 120. MEXICO NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 121. MEXICO NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY DIGITAL PCR, 2018-2024 (USD MILLION)
TABLE 122. MEXICO NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY DIGITAL PCR, 2025-2030 (USD MILLION)
TABLE 123. MEXICO NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 124. MEXICO NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 125. MEXICO NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 126. MEXICO NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 127. MEXICO NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY CANCER SCREENING, 2018-2024 (USD MILLION)
TABLE 128. MEXICO NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY CANCER SCREENING, 2025-2030 (USD MILLION)
TABLE 129. MEXICO NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY PRENATAL TESTING, 2018-2024 (USD MILLION)
TABLE 130. MEXICO NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY PRENATAL TESTING, 2025-2030 (USD MILLION)
TABLE 131. MEXICO NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 132. MEXICO NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 133. MEXICO NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. MEXICO NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY DIGITAL PCR, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY DIGITAL PCR, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY CANCER SCREENING, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY CANCER SCREENING, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY PRENATAL TESTING, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY PRENATAL TESTING, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY DIGITAL PCR, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY DIGITAL PCR, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY CANCER SCREENING, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY CANCER SCREENING, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY PRENATAL TESTING, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY PRENATAL TESTING, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY DIGITAL PCR, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY DIGITAL PCR, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY CANCER SCREENING, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY CANCER SCREENING, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY PRENATAL TESTING, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY PRENATAL TESTING, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY DIGITAL PCR, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY DIGITAL PCR, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY CANCER SCREENING, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY CANCER SCREENING, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY PRENATAL TESTING, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY PRENATAL TESTING, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. GERMANY NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 202. GERMANY NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 203. GERMANY NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY DIGITAL PCR, 2018-2024 (USD MILLION)
TABLE 204. GERMANY NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY DIGITAL PCR, 2025-2030 (USD MILLION)
TABLE 205. GERMANY NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 206. GERMANY NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 207. GERMANY NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 208. GERMANY NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 209. GERMANY NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY CANCER SCREENING, 2018-2024 (USD MILLION)
TABLE 210. GERMANY NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY CANCER SCREENING, 2025-2030 (USD MILLION)
TABLE 211. GERMANY NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY PRENATAL TESTING, 2018-2024 (USD MILLION)
TABLE 212. GERMANY NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY PRENATAL TESTING, 2025-2030 (USD MILLION)
TABLE 213. GERMANY NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 214. GERMANY NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 215. GERMANY NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. GERMANY NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. FRANCE NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 218. FRANCE NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 219. FRANCE NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY DIGITAL PCR, 2018-2024 (USD MILLION)
TABLE 220. FRANCE NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY DIGITAL PCR, 2025-2030 (USD MILLION)
TABLE 221. FRANCE NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 222. FRANCE NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 223. FRANCE NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 224. FRANCE NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 225. FRANCE NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY CANCER SCREENING, 2018-2024 (USD MILLION)
TABLE 226. FRANCE NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY CANCER SCREENING, 2025-2030 (USD MILLION)
TABLE 227. FRANCE NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY PRENATAL TESTING, 2018-2024 (USD MILLION)
TABLE 228. FRANCE NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY PRENATAL TESTING, 2025-2030 (USD MILLION)
TABLE 229. FRANCE NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 230. FRANCE NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 231. FRANCE NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. FRANCE NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY DIGITAL PCR, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY DIGITAL PCR, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY CANCER SCREENING, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY CANCER SCREENING, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY PRENATAL TESTING, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY PRENATAL TESTING, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. ITALY NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 250. ITALY NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 251. ITALY NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY DIGITAL PCR, 2018-2024 (USD MILLION)
TABLE 252. ITALY NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY DIGITAL PCR, 2025-2030 (USD MILLION)
TABLE 253. ITALY NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 254. ITALY NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 255. ITALY NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 256. ITALY NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 257. ITALY NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY CANCER SCREENING, 2018-2024 (USD MILLION)
TABLE 258. ITALY NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY CANCER SCREENING, 2025-2030 (USD MILLION)
TABLE 259. ITALY NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY PRENATAL TESTING, 2018-2024 (USD MILLION)
TABLE 260. ITALY NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY PRENATAL TESTING, 2025-2030 (USD MILLION)
TABLE 261. ITALY NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 262. ITALY NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 263. ITALY NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. ITALY NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. SPAIN NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 266. SPAIN NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 267. SPAIN NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY DIGITAL PCR, 2018-2024 (USD MILLION)
TABLE 268. SPAIN NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY DIGITAL PCR, 2025-2030 (USD MILLION)
TABLE 269. SPAIN NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 270. SPAIN NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 271. SPAIN NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 272. SPAIN NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 273. SPAIN NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY CANCER SCREENING, 2018-2024 (USD MILLION)
TABLE 274. SPAIN NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY CANCER SCREENING, 2025-2030 (USD MILLION)
TABLE 275. SPAIN NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY PRENATAL TESTING, 2018-2024 (USD MILLION)
TABLE 276. SPAIN NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY PRENATAL TESTING, 2025-2030 (USD MILLION)
TABLE 277. SPAIN NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 278. SPAIN NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 279. SPAIN NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. SPAIN NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY DIGITAL PCR, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY DIGITAL PCR, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY CANCER SCREENING, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY CANCER SCREENING, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY PRENATAL TESTING, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY PRENATAL TESTING, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 298. SAUDI ARABIA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY DIGITAL PCR, 2018-2024 (USD MILLION)
TABLE 300. SAUDI ARABIA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY DIGITAL PCR, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY CANCER SCREENING, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY CANCER SCREENING, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY PRENATAL TESTING, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY PRENATAL TESTING, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA NON-INVASIVE LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 312. SAUDI ARABIA NON-INVASIVE LIQUID BIOPSY MAR

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Non-Invasive Liquid Biopsy market report include:
  • Roche Diagnostics International AG
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • QIAGEN N.V.
  • Guardant Health, Inc.
  • Natera, Inc.
  • Foundation Medicine, Inc.
  • Grail, Inc.
  • Bio-Rad Laboratories, Inc.
  • Exact Sciences Corporation

Table Information

Report AttributeDetails
No. of Pages188
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.41 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.25 Billion
Compound Annual Growth Rate18.1%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Liquid Biopsy Market Report by Product and Service, Circulating Biomarker, Cancer Type, End User, and Region 2025-2033 - Product Image

Liquid Biopsy Market Report by Product and Service, Circulating Biomarker, Cancer Type, End User, and Region 2025-2033

  • Report
  • 146 Pages
  • Global
From
Liquid Biopsy Market Report by Product, Application, Circulating Biomarkers, End-User Countries and Company Analysis 2025-2033 - Product Image

Liquid Biopsy Market Report by Product, Application, Circulating Biomarkers, End-User Countries and Company Analysis 2025-2033

  • Report
  • 230 Pages
  • Global
From
Breast Cancer Liquid Biopsy Market Report by Product Services, Circulating Biomarker, End User, and Region 2025-2033 - Product Image

Breast Cancer Liquid Biopsy Market Report by Product Services, Circulating Biomarker, End User, and Region 2025-2033

  • Report
  • 150 Pages
  • Global
From
Liquid Biopsy Market by Product Type, Application, Biomarker Type, Technology, Indication, and End-User - Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles and Market Forecast, 2025-2035 - Product Image

Liquid Biopsy Market by Product Type, Application, Biomarker Type, Technology, Indication, and End-User - Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles and Market Forecast, 2025-2035

  • Report
  • 235 Pages
  • Global
From
Liquid Biopsy Market Industry Trends and Global Forecasts to 2035, by Application, Target Disease Indication, Type of Circulating Biomarker, Type of Sample, End-user, Type of Technique, and Key Geographical Regions - Product Image

Liquid Biopsy Market Industry Trends and Global Forecasts to 2035, by Application, Target Disease Indication, Type of Circulating Biomarker, Type of Sample, End-user, Type of Technique, and Key Geographical Regions

  • Report
  • 331 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.